Metera Pharmaceuticals Inc. — Form D/A
Metera Pharmaceuticals Inc. of Somerville, MA, a company, filed a Form D amendment with the SEC on 2018-06-11. The offering totals $8.6M, of which $8.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-06-11
- Form: D/A
- Accession: 0001693559-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $8.6M
- Amount sold: $8.6M
- Investors: 1
- Date of first sale: 2016-12-15
- Revenue range: Decline to Disclose
- SEC file number: 021-277409
Issuer
- Name: Metera Pharmaceuticals Inc.
- CIK: 0001693559
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 240 Elm Street, Somerville, MA, 02144
- Phone: 617-312-5367
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Meredith C Fisher, Ph.D. | Director | Somerville, MA |
| Marc Lenburg, Ph.D. | Director | Somerville, MA |
| Marc Lenburg, Ph.D. | Executive Officer | Somerville, MA |
| VIJAY MURTHY | Director | WATERTOWN, MA |
| Vijay Murthy, Ph.D. | Director | Newton, MA |
| Avrum Spira, M.D. | Director | Newton, MA |
| Avrum Spira, M.D. | Executive Officer | Newton, MA |
| Marc Lenburg | Director | Newton, MA |
| Marc Lenburg | Executive Officer | Newton, MA |
| Avrum Spira | Executive Officer | Newton, MA |
Other filings by this issuer (2)
More